As shown in Figures 5A,B, more p-c-Fos and p-c-Jun were accumulated on the nuclei of both breast cancer cells after IL-1β treatment, compared with the untreated control breast cancer cells indicating upregulated p-c-Fos and p-c-Jun. This evidence concerns the gene FOS and breast cancer.